Clinatec aims to make diagnosing cardiac arrhythmia and epilepsy easier

Could magnetocardiography (MCG) and magnetoencephalography (MEG) one day be available to the masses? Clinatec is currently running a clinical trial to find the answer. The trial, named Minimag, will test the signal-recording capacities of an optically-pumped helium-4 magnetometer, originally designed for the Swarm space mission, on sixteen volunteer subjects.

MCG and MEG would be extremely useful to practitioners in locating the exact source of anomalies like cardiac arrhythmia and epilepsy before administering treatment or surgery. However, the technologies require 4 Kelvin cooling systems and magnetic shielding of at least five tons, which only a few research institutes in the world can provide. Leti’s magnetometers would remove this hurdle, potentially making these valuable diagnostic tests available to a wider population.

Contact: etienne.labyt@cea.fr

Facebook

Twitter